At Impact Proteomics, our patented ProMTag reversible chemistry powers our immune profiling and sample preparation technology. IP-to-MS is the first truly unbiased platform technology for antigen identification and discovery. Our Multiomics and Proteomics workflows utilize the ProMTag for fast, high-yield sample preparation.
Separate immunoprecipitated proteins from immunoglobulins with our IP-to-MS workflow, facilitating identification of novel antigen targets in an unbiased manner.
Prepare high-quality, sequencing-ready DNA and RNA and either intact proteins or mass spectrometry-ready peptides for whole proteome analysis from a single starting sample with our Multiomics method.
Capture and cleanup whole proteomes for top-down or bottom-up analysis using ProMTag with our Proteomics method
"The IP-to-MS technology represents an extremely powerful tool in the assessment of specific humoral immune responses, with applications that range from rheumatic disease to cancer biology. This radiolabel-free approach offers the opportunity to readily detect novel autoantibody autoantigen combinations for improved characterization of immune responses, a process that was previously limited by technical factors associated with conventional immunoprecipitation methods."
-- Chief of Rheumatology, Leading Autoimmune Research Institution
Recent News and Updates
- Impact Proteomics Joins Science Exchange November 4, 2024
- Impact Proteomics Featured as one of the Top 5 Biotech Startups Advancing Biochemistry Solutions by StartUs Insights October 10, 2024
- Analytical Chemistry Startups Features Impact Proteomics and the “ProMTag Promise” September 9, 2024
- Impact Proteomics Listed Among 100 Top Diagnostics Companies and Startups in the United States by F6S August 21, 2024
- Dr. Frederick Strathmann Joins Impact Proteomics’ Board of Directors August 15, 2024